Investigation of efficacy of pentosan polysulfate in IC/BPS with lower urinary tract symptom using portable uroflometry and flow chart.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003772

Enrollment

Registered

2019-04-15

Start date

2020-09-21

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Experimental group : 12-week PPS + a-blocker combination therapy in patients with interstitial cystitis / Control group : 12-week a-blocker treatment in patients with interstitial cystitis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Those who are clinically eligible for interstitial cystitis criteria - 45 years old or older - Those with an IPSS total score of 8 or higher - voluntarily agreed to this study in writing

Exclusion criteria

Exclusion criteria: - Those who have undergone intravesical treatment (Hydrodistention, DMSO, intravesical PPS) within 4 weeks - who underwent cystoscopy within 4 weeks - Those taking antidepressants, antihistamines, anticonvulsants, anticholinergics, and Beta3 agonists within 4 weeks - Positive test for urine cytology in pre-test - Positive culture test for pre-test - Those who can not use the portable urine recorder

Design outcomes

Primary

Measure	Time frame
ICSI(Interstitial Cystitis Symptom Index)	—

Secondary

Measure	Time frame
functional bladder capacity, ICPI (Interstitial Cystitis Problem Index), PUF (Pelvic Pain and Urgency/Frequency Patient Symptom Scale)	—

Countries

Korea, Republic of

Contacts

Public ContactDUGEON MOON

Koera University Guro Hospital

uromoon@gmail.com+82-2-2626-1310

Outcome results